Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmic Business News
Clobetasol propionate ophthalmic suspension 0.05% approved for postop inflammation, pain
The FDA approved clobetasol propionate ophthalmic suspension 0.05% for the treatment of inflammation and pain after ocular surgery, according to a press release from Formosa Pharmaceuticals and AimMax Therapeutics.
Sandoz completes acquisition of ranibizumab biosimilar
Sandoz has completed the acquisition of Cimerli, a ranibizumab biosimilar, from Coherus BioSciences, according to a press release.
Log in or Sign up for Free to view tailored content for your specialty!
Retirement planning involves three long-term keys to success
The number one financial goal for most doctors is, by far, getting to a comfortable retirement on their own timeline and with the lifestyle they want.
PulseSight Therapeutics launches with focus on non-viral gene therapies
PulseSight Therapeutics, which is developing non-viral gene therapies for retinal diseases, has launched with seed financing from Pureos Bioventures and ND Capital, according to a press release.
Leadership changes strengthen Ocular Therapeutix’s focus on retina care
Ocular Therapeutix announced changes to its leadership and board of directors to strengthen its focus on retina care.
VIDEO: Verséa offers amniotic membrane graft, point-of-care testing platform
WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Rahim Hirji, RPh, describes the products available from Verséa Ophthalmics.
Live from Hawaiian Eye 2024
John A. Hovanesian, MD, FACS, and Jim Mazzo sit down with guests Eric D. Donnenfeld, MD, Calvin C. Roberts, MD, Mark L. Baum and Jeannette Bankes to discuss private equity, industry breakthroughs and more.
Opthea appoints Arshad M. Khanani as chief medical advisor
Arshad M. Khanani, MD, MA, FASRS, a renowned retina specialist and clinical researcher, has been appointed as chief medical advisor of Opthea Limited, according to a press release.
VIDEO: Office-based surgery holds potential but faces financial, legislative challenges
TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Kendall E. Donaldson, MD, MS, discusses the benefits of office-based surgery while highlighting some of its obstacles.
Harrow licenses 5 ophthalmic products to Canada-based Apotex
Harrow has announced an exclusive out-licensing agreement with Apotex, a major Canadian pharmaceutical company, to market and distribute five of the company’s branded ophthalmic products.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read